e-Drug3D

150

DESLANOSIDE

DISCONTINUED

INN
DESLANOSIDE

cas 17598-65-1

CLASS

CARDIOVASCULAR
CARDIOTONIC AGENTS

ROUTE (list)

INJECTION

ATC code

C01AA07

PK parameters

t1/2 51 HOUR (PMID6168847)

Target

TARGET SODIUM/POTASSIUM ATPASE

DrugCentral

Sodium,potassium-transporting ATPase UNIPROT P05023 ATP1A1

Download SDF file

4-[(3S,5R,8R,9R,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one

Formula:
C47H74O19

Calculated chemical properties:

MW 943.06
NB_atoms 66
XLogP 0.04
PSA 277.212
NB_HD 9
NB_HA 19
fsp3 0.94
Lipinski(0=no;1=yes) 0

FDA
NDA 009282 (pdf not found) INN (DESLANOSIDE) CEDILANID-D (NOVARTIS) APPROVAL= - YEAR= 0 DISCONTINUED